New oxadiazole and pyrazoline derivatives as anti-proliferative agents targeting EGFR-TK: design, synthesis, biological evaluation and molecular docking study

MI Serag, SS Tawfik, SMI Badr, HM Eisa - Scientific Reports, 2024 - nature.com
Two new series of oxadiazole and pyrazoline derivatives were designed and synthesized as
promising EGFR-TK inhibitors. The in vitro antiproliferative activity was studied against three …

New series of isoxazole derivatives targeting EGFR-TK: Synthesis, molecular modeling and antitumor evaluation

ET Warda, IA Shehata, MB El-Ashmawy… - Bioorganic & Medicinal …, 2020 - Elsevier
New series of isoxazole derivatives were synthesized and evaluated for in vitro antitumor
activity against HepG2, MCF-7 and HCT-116 cancer cells. Results showed that 4b and 25a …

Novel Pyrazoloquinolin-2-ones: Design, synthesis, docking studies, and biological evaluation as antiproliferative EGFR-TK inhibitors

MAI Elbastawesy, AA Aly, M Ramadan… - Bioorganic …, 2019 - Elsevier
Two new series of diethyl 2-[2-(substituted-2-oxo-1, 2-dihydroquinolin-4-yl) hydrazono]-
succinates 6a-g and 1-(2-oxo-1, 2-dihydroquinolin-4-yl)-1H-pyrazoles 7a-f have been …

Design, synthesis and in vitro anti-proliferative activity of 4, 6-quinazolinediamines as potent EGFR-TK inhibitors

S Mowafy, NA Farag, KAM Abouzid - European Journal of Medicinal …, 2013 - Elsevier
4-Anilino-6-substituted-quinazolines were designed, synthesized and evaluated for EGFR-
TK and tumor growth inhibitory activities. The target compounds were designed with …

Design, synthesis and biological evaluation of a new series of thiazolyl-pyrazolines as dual EGFR and HER2 inhibitors

B Sever, MD Altıntop, MO Radwan, A Özdemir… - European journal of …, 2019 - Elsevier
Epidermal growth factor receptor (EGFR, also known as HER1) and HER2, prominent
members of receptor tyrosine kinase (RTK) superfamily, have been reported as diagnostic or …

Discovery of 3, 3 a, 4, 5-tetrahydro-2 H-benzo [g] indazole containing quinoxaline derivatives as novel EGFR/HER-2 dual inhibitors

X Zong, J Cai, J Chen, C Sun, L Li, M Ji - RSC Advances, 2015 - pubs.rsc.org
In the present study, twenty-five pyrazole–quinoxaline derivatives (4a–4y) were designed
and synthesized, and their biological activity as potential EGFR or HER-2 kinase inhibitors …

Novel 2-(5-Aryl-4, 5-dihydropyrazol-1-yl) thiazol-4-one as EGFR inhibitors: synthesis, biological assessment and molecular docking insights

T Al-Warhi, AM El Kerdawy, MA Said… - Drug Design …, 2023 - Taylor & Francis
Introduction Epidermal growth factor receptor (EGFR) regulates several cell functions which
include cell growth, survival, multiplication, differentiation, and apoptosis. Currently, EGFR …

New Thiazolyl-Pyrazoline derivatives as potential dual EGFR/HER2 inhibitors: design, synthesis, anticancer activity evaluation and in silico study

MM Fakhry, AA Mattar, M Alsulaimany, EM Al-Olayan… - Molecules, 2023 - mdpi.com
A new series of thiazolyl-pyrazoline derivatives (4a–d, 5a–d 6a, b, 7a–d, 8a, b, and 10a, b)
have been designed and synthesized through the combination of thiazole and pyrazoline …

Design, synthesis, biological evaluation and docking study of novel quinazoline derivatives as EGFR-TK inhibitors

H Jin, BX Wu, Q Zheng, CH Hu, XZ Tang… - Future Medicinal …, 2021 - Taylor & Francis
Background: Quinazoline-based compounds have been proved effective in the treatment of
cancers for years. Materials & methods: The structural features of several inhibitors of EGFR …

Harnessing molecular hybridization approach to discover novel quinoline EGFR-TK inhibitors for cancer treatment

N Ryad, AA Elmaaty, IM Ibrahim… - Future Medicinal …, 2024 - Taylor & Francis
Aim: Using molecular hybridization approach, novel 18 quinoline derivatives (6a–11) were
designed and synthesized as EGFR-TK inhibitors. Materials & methods: The antiproliferative …